Author:
Buckley Anne F.,Burgart Lawrence J.,Sahai Vaibhav,Kakar Sanjay
Publisher
Oxford University Press (OUP)
Reference41 articles.
1. El-Serag HB, Davila JA, Petersen NJ, et al. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update [published correction appears in Ann Intern Med. 2004;140:151]. Ann Intern Med. 2003;139:817-823.
2. Farmer DG, Rosove MH, Shaked A, et al. Current treatment modalities for hepatocellular carcinoma. Ann Surg. 1994;219:236-247.
3. Tanaka H. Immunohistochemical studies on epidermal growth factor receptor in hepatocellular carcinoma. Nippon Shokakibyo Gakkai Zasshi. 1991;88:138-144.
4. Tang Z, Qin L, Wang X, et al. Alterations of oncogenes, tumor suppressor genes and growth factors in hepatocellular carcinoma: with relation to tumor size and invasiveness. Chin Med J (Engl). 1998;111:313-318.
5. El-Bassiouni A, Nosseir M, Zoheiry M, et al. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma. APMIS. 2006;114:420-427.
Cited by
143 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献